CAS: 254964-60-8 - 4-Hydroxy-N-[4-(trifluoromethyl)phenyl]-5-methoxy-N,1-dimethyl-2-oxo-1,2-dihydroquinoline-3-carboxamide
Formel:C20H17F3N2O4
InChl:InChI=1S/C20H17F3N2O4/c1-24(12-9-7-11(8-10-12)20(21,22)23)18(27)16-17(26)15-13(25(2)19(16)28)5-4-6-14(15)29-3/h4-10,26H,1-3H3
InChI Key:InChIKey=ONDYALNGTUAJDX-UHFFFAOYSA-N
SMILES:O=C(C=1C(=O)N(C=2C=CC=C(OC)C2C1O)C)N(C3=CC=C(C=C3)C(F)(F)F)C
- Synonyme:
- 1,2-Dihydro-4-hydroxy-5-methoxy-N,1-dimethyl-2-oxo-N-[4-(trifluoromethyl)phenyl]-3-quinolinecarboxamide
- 3-Quinolinecarboxamide, 1,2-dihydro-4-hydroxy-5-methoxy-N,1-dimethyl-2-oxo-N-[4-(trifluoromethyl)phenyl]-
- 4-Hydroxy-5-methoxy-N-methyl-1-methyl-2-oxo-N-(4-trifluoromethylphenyl)-1,2-dihydroquinoline-3-carboxamide
- Abr 215050
- Abr-5050
- N-Methyl-N-(4-trifluoromethylphenyl)-1,2-dihydro-4-hydroxy-5-methoxy-1-methyl-2-oxoquinoline-3-carboxamide
- Tasquinimod
Marke | Produktdaten | Reinheit | Preisklasse | Voraussichtliche Lieferung |
---|---|---|---|---|
tasquinimod REF: IN-DA00BF4VCAS: 254964-60-8 | 98% | Nachfragen | Di 10 Dez 24 | |
Tasquinimod REF: TM-T6695CAS: 254964-60-8 | 100% - 99.69% | 97,00 €~2.174,00 € | Mo 16 Dez 24 | |
Tasquinimod REF: TR-T007820CAS: 254964-60-8 | - - - | 5.351,00 € | Fr 17 Jan 25 | |
Tasquinimod REF: 3D-FT76139CAS: 254964-60-8 | Min. 95% | - - - | Ausgelaufenes produkt |
tasquinimod
Ref: IN-DA00BF4V
5mg | 188,00 € | ||
10mg | 207,00 € | ||
50mg | 245,00 € | ||
100mg | 576,00 € | ||
250mg | Nachfragen |
Tasquinimod
Ref: TM-T6695
1mg | 97,00 € | ||
2mg | 154,00 € | ||
5mg | 205,00 € | ||
10mg | 336,00 € | ||
25mg | 402,00 € | ||
50mg | 524,00 € | ||
100mg | 777,00 € | ||
500mg | 2.174,00 € | ||
1mL*10mM (DMSO) | 178,00 € |
Tasquinimod
Kontrolliertes ProduktRef: TR-T007820
250mg | 5.351,00 € |
Tasquinimod
Ref: 3D-FT76139
1mg | Ausgelaufen | Anforderung von Informationen | |
2mg | Ausgelaufen | Anforderung von Informationen | |
5mg | Ausgelaufen | Anforderung von Informationen | |
10mg | Ausgelaufen | Anforderung von Informationen | |
25mg | Ausgelaufen | Anforderung von Informationen |